Persistent Pulmonary Hypertension of the Newborn Clinical Trial
Official title:
Population Pharmacokinetics and Dosage Individualization of Bosentan, Sildenafil and Tadalafil in Persistent Pulmonary Hypertension of the Newborn
The use of bosentan, sildenafil and tadalafil in neonates with persistent pulmonary hypertension (PPHN) depends mostly on the empirical experience of pediatricians. Moreover, the recommended dose of those three drugs in treating PPHN remains controversial. Therefore, our aim is to study the pharmacokinetics and pharmacodynamics of bosentan, sildenafil and tadalafil in neonates of PPHN then dose a tailor-made therapeutic regimen.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04328636 -
Nebulized MgSO4 in Persistent Pulmonary Hypertension of Newborn
|
Phase 1/Phase 2 | |
Recruiting |
NCT02380040 -
Plethismographic Perfusion Index in Neonates
|
N/A | |
Withdrawn |
NCT01360671 -
IV Sildenafil Persistent Pulmonary Hypertension Of The Newborn
|
Phase 2 | |
Terminated |
NCT02261883 -
Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
|
Phase 2 | |
Completed |
NCT04841070 -
NEURodevelopmental Outcome After Persistent Pulmonary Hypertension Of the Newborn
|
N/A | |
Recruiting |
NCT05741229 -
The Effect Of Nebulizied Nitroglycerin As An Adjuvant Therapy For Persistent Pulmonary Hypertension Of Newborns
|
N/A | |
Recruiting |
NCT00710177 -
PTGS1 Genetic Variation and Increased Risk for Persistent Pulmonary Hypertension of the Newborn
|
||
Completed |
NCT01670136 -
Pharmacokinetics of Sildenafil in Premature Infants
|
Phase 1 | |
Completed |
NCT02940327 -
Markers of Inflammation and Lung Recovery in ECMO Patients for PPHN
|
||
Terminated |
NCT01389856 -
Persistent Pulmonary Hypertension of the Newborn
|
Phase 3 | |
Terminated |
NCT01069861 -
Study To Investigate Safety And Efficacy Of Sildenafil In The Newborns With Persistent Pulmonary Hypertension (PPHN)
|
Phase 2 | |
Active, not recruiting |
NCT02951130 -
Milrinone in Congenital Diaphragmatic Hernia
|
Phase 2 | |
Enrolling by invitation |
NCT04938167 -
Preductal Oxygen Saturation Target in Term and Late Preterm Neonates With Hypoxemic Respiratory Failure or Pulmonary Hypertension
|
N/A |